Study of Glycemic Control on Liver Transplantation Outcomes
Completed · Phase 4
Conditions studied: Evidence of Liver Transplantation, Hyperglycemia, Rejection
In brief
Many but not all studies have shown improvement in morbidity and mortality with intensive glycemic management postoperatively. In this study, the investigators propose to determine whether improved glycemic control using intensive insulin treatment immediately postoperatively will improve outcomes in patients undergoing liver transplant using a prospective, controlled, randomized, parallel-group study design targeting two different glucose levels, 140 and 180 mg/dL.
Key facts
- Study ID
- NCT01211730
- Run by
- Northwestern University
- People needed
- 164
- Starts
- 2009-04-01
- Expected to finish
- 2016-05-01
- Last updated by the study team
- 2016-12-23
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Require Liver Transplantation
- Age 18 - 80
- Able to give informed consent personally or via a family member who has appropriate authorization to do so if patient unconscious.
- Expected survival following transplantation for > 1 year.
- Glucose level over 180 mg/dL postoperatively
You may not qualify if…
- Inability of patient or family member to give informed consent
- Not expected to survive for > 1 year following liver transplantation.
- Previous liver transplantation
- Acute liver failure
- Living related donor
Where it is running
- Northwestern University Feinberg School of Medicine — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.